Tert -butylhydroquinone augments Nrf2-dependent resilience against oxidative stress and improves survival of ventilator-induced lung injury in mice

Oxidative stress caused by mechanical ventilation contributes to the pathophysiology of ventilator-induced lung injury (VILI). A key mechanism maintaining redox balance is the upregulation of nuclear factor-erythroid-2-related factor 2 (Nrf2)-dependent antioxidant gene expression. We tested whether pretreatment with an Nrf2-antioxidant response element (ARE) pathway activator -butylhydroquinone (tBHQ) protects against VILI. Male C57BL/6J mice were pretreated with an intraperitoneal injection of tBHQ ( = 10), an equivalent volume of 3% ethanol (EtOH3%, vehicle, = 13), or phosphate-buffered saline (controls, = 10) and were then subjected to high tidal volume (HV ) ventilation for a maximum of 4 h. HV ventilation severely impaired arterial oxygenation ( = 49 ± 7 mmHg, means ± SD) and respiratory system compliance, resulting in a 100% mortality among controls. Compared with controls, tBHQ improved arterial oxygenation ( = 90 ± 41 mmHg) and respiratory system compliance after HV ventilation. In addition, tBHQ attenuated the HV ventilation-induced development of lung edema and proinflammatory response, evidenced by lower concentrations of protein and proinflammatory cytokines (IL-1β and TNF-α) in the bronchoalveolar lavage fluid, respectively. Moreover, tBHQ enhanced the pulmonary redox capacity, indicated by enhanced Nrf2-depentent gene expression at baseline and by the highest total glutathione concentration after HV ventilation among all groups. Overall, tBHQ pretreatment resulted in 60% survival ( < 0.001 vs. controls). Interestingly, compared with controls, EtOH3% reduced the proinflammatory response to HV ventilation in the lung, resulting in 38.5% survival ( = 0.0054 vs. controls). In this murine model of VILI, tBHQ increases the pulmonary redox capacity by activating the Nrf2-ARE pathway and protects against VILI. These findings support the efficacy of pharmacological Nrf2-ARE pathway activation to increase resilience against oxidative stress during injurious mechanical ventilation.